posts browsing tag

MOU

–  License and Supply Agreement with Thermo Fisher Scientific signed at Macrogen headquarters – Further development of the global CES market expected by expanding Macrogen’s “Genome Supermarket” strategy SEOUL, South Korea–Kap-Seok Yang, CEO of Macrogen (KOSDAQ: 038290), announced on January 13 that the company …

Continue reading

Contract signed for Macrogen to become the exclusive buyer of ‘Exosome Plus’ high-efficiency exosome isolation kit, ‘Exo2D™’ MOU signed for the joint development of exosome-based diagnostic and treatment solutions Cooperative efforts being made to enter exosome-based biomedicine market through joint research and business collaboration SEOUL, South Korea …

Continue reading